Harpoon Therapeutics, Inc.
NASDAQ:HARP
23.01 (USD) • At close March 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.448 | 20.221 | 8.583 | 4.089 | 13.617 | 8.303 | 5.906 | 4.325 | 4.484 | 5.838 | 9.007 | 7.492 | 3.893 | 2.762 | 3.297 | 2.234 | 1.417 | 1.063 | 1.063 | 1.063 | 1.063 | 1.063 | 1.563 | 0.708 |
| Cost of Revenue
| 0.236 | 0.568 | 1.105 | 0.91 | 0.706 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 4.212 | 19.653 | 7.478 | 3.179 | 12.911 | 8.303 | 5.906 | 4.325 | 4.484 | 5.838 | 9.007 | 7.492 | 3.893 | 2.762 | 3.297 | 2.234 | 1.417 | 1.063 | 1.063 | 1.063 | 1.063 | 1.063 | 1.563 | 0.708 |
| Gross Profit Ratio
| 0.947 | 0.972 | 0.871 | 0.777 | 0.948 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 12.325 | 12.196 | 15.163 | 18.947 | 20.977 | 20.651 | 20.818 | 20.664 | 16.973 | 18.271 | 16.216 | 15.065 | 13.057 | 11.924 | 12.519 | 12.706 | 9.533 | 9.971 | 9.382 | 8.717 | 5.967 | 6.151 | 5.533 | 4.79 |
| General & Administrative Expenses
| 4.262 | 3.803 | 4.185 | 3.854 | 4.529 | 5.063 | 5.401 | 5.202 | 4.186 | 4.335 | 4.604 | 3.924 | 4.428 | 3.945 | 3.913 | 4.333 | 8.493 | 3.734 | 5.832 | 2.215 | 1.942 | 0.967 | 0.982 | 0.912 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.262 | 3.803 | 4.185 | 3.854 | 4.529 | 5.063 | 5.401 | 5.202 | 4.186 | 4.335 | 4.604 | 3.924 | 4.428 | 3.945 | 3.913 | 4.333 | 8.493 | 3.734 | 5.832 | 2.215 | 1.942 | 0.967 | 0.982 | 0.912 |
| Other Expenses
| 11.903 | -0.488 | -0.86 | -0.05 | -0.04 | -0.044 | -0.048 | -0.047 | -0.055 | -0.058 | -0.051 | -0.011 | -0.014 | 0 | -0.001 | 0.004 | -0.026 | -0.015 | 0.04 | -0.008 | -0.022 | 0 | -0.002 | 0.075 |
| Operating Expenses
| 16.587 | 15.999 | 19.348 | 22.801 | 25.506 | 25.714 | 26.219 | 25.866 | 21.159 | 22.606 | 20.82 | 18.989 | 17.485 | 15.869 | 16.432 | 17.039 | 18.026 | 13.705 | 15.214 | 10.932 | 7.909 | 7.118 | 6.515 | 5.702 |
| Operating Income
| -12.139 | 2.493 | -10.765 | -18.712 | -11.889 | -17.411 | -20.313 | -21.541 | -16.675 | -16.768 | -61.767 | -11.497 | -13.592 | -13.107 | -13.135 | -14.805 | -16.609 | -12.642 | -14.151 | -9.869 | -6.846 | -6.055 | -4.952 | -4.994 |
| Operating Income Ratio
| -2.729 | 0.123 | -1.254 | -4.576 | -0.873 | -2.097 | -3.439 | -4.981 | -3.719 | -2.872 | -6.858 | -1.535 | -3.491 | -4.745 | -3.984 | -6.627 | -11.721 | -11.893 | -13.312 | -9.284 | -6.44 | -5.696 | -3.168 | -7.054 |
| Total Other Income Expenses Net
| 10.337 | -2.217 | -0.573 | 0.292 | 0.249 | 0.06 | -0.008 | -0.047 | -0.055 | -0.058 | -50.005 | -0.011 | -0.014 | 0.415 | -0.001 | 0.004 | -0.026 | -0.015 | 0.04 | -0.008 | -0.022 | -0.005 | -0.002 | 0.075 |
| Income Before Tax
| -1.802 | 1.06 | -11.338 | -18.42 | -11.64 | -17.351 | -20.321 | -21.552 | -16.682 | -16.764 | -61.724 | -11.357 | -13.307 | -12.692 | -12.552 | -14.269 | -15.908 | -11.817 | -13.579 | -9.729 | -6.759 | -5.994 | -4.881 | -4.94 |
| Income Before Tax Ratio
| -0.405 | 0.052 | -1.321 | -4.505 | -0.855 | -2.09 | -3.441 | -4.983 | -3.72 | -2.872 | -6.853 | -1.516 | -3.418 | -4.595 | -3.807 | -6.387 | -11.227 | -11.117 | -12.774 | -9.152 | -6.358 | -5.639 | -3.123 | -6.977 |
| Income Tax Expense
| -0.236 | 1.071 | 0.711 | -0.345 | -0.249 | -0.06 | 0.008 | -0.036 | -0.048 | -0.062 | 49.86 | -0.688 | -0.299 | 0 | -0.584 | -1.032 | -0.531 | -1.139 | -0.532 | -0.205 | -0.109 | -0.061 | -0.073 | 0.075 |
| Net Income
| -1.802 | 1.061 | -12.049 | -18.075 | -11.391 | -17.291 | -20.329 | -21.552 | -16.682 | -16.764 | -61.724 | -11.357 | -13.307 | -12.692 | -12.552 | -14.269 | -15.908 | -11.817 | -13.579 | -9.729 | -6.759 | -5.994 | -4.881 | -4.94 |
| Net Income Ratio
| -0.405 | 0.052 | -1.404 | -4.42 | -0.837 | -2.083 | -3.442 | -4.983 | -3.72 | -2.872 | -6.853 | -1.516 | -3.418 | -4.595 | -3.807 | -6.387 | -11.227 | -11.117 | -12.774 | -9.152 | -6.358 | -5.639 | -3.123 | -6.977 |
| EPS
| -0.46 | 0.3 | -3.26 | -5.37 | -3.45 | -5.23 | -6.18 | -6.6 | -5.1 | -5.2 | -19.5 | -4.5 | -5.3 | -5.1 | -5.1 | -5.8 | -6.5 | -4.9 | -9.2 | -4.07 | -7.15 | -6.34 | -5.17 | -0.52 |
| EPS Diluted
| -0.46 | 0.3 | -3.26 | -5.37 | -3.45 | -5.23 | -6.18 | -6.6 | -5.1 | -5.2 | -19.5 | -4.5 | -5.3 | -5.1 | -5.1 | -5.8 | -6.5 | -4.9 | -9.2 | -4.07 | -7.15 | -6.34 | -5.17 | -0.52 |
| EBITDA
| -12.139 | 4.719 | -10.538 | -18.712 | -11.362 | -16.863 | -19.709 | -20.983 | -16.141 | -16.219 | 38.69 | -11.497 | -13.062 | -12.595 | -12.632 | -14.805 | -16.609 | -12.642 | -13.854 | -9.729 | -6.687 | -5.901 | -4.813 | -4.818 |
| EBITDA Ratio
| -2.729 | 0.233 | -1.228 | -4.576 | -0.834 | -2.031 | -3.337 | -4.852 | -3.6 | -2.778 | 4.296 | -1.535 | -3.355 | -4.56 | -3.831 | -6.627 | -11.721 | -11.893 | -13.033 | -9.152 | -6.291 | -5.551 | -3.079 | -6.805 |